Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
Atsushi Nakajima, Mitsunori Seki, Shinya Taniguchi, Akira Ohta, Per Göran Gillberg, Jan P. Mattsson, Michael Camilleri
Dive into the research topics of 'Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial'. Together they form a unique fingerprint.